Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

8.860 USD +0.230 (+2.67%)
Streaming Delayed Price Updated: 11:50 AM EDT, Jul 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aldeyra Therapeu

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Thinking about buying stock in Immunome, Aldeyra Therapeutics, New Oriental Education, ConforMIS, or Cytokinetics?
InvestorsObserver issues critical PriceWatch Alerts for IMNM, ALDX, EDU, CFMS, and CYTK. 
From PR Newswire
Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate
TheFDA has granted Orphan Drug DesignationtoAldeyra Therapeutics Inc's(NASDAQ: ALDX) ADX-2191 ... 
Tags Biotech Small Cap News
From Benzinga
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company for ADX-2191 (methotrexate for... 
From Business Wire News Releases
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. ... 
Tags SXTC Top Gainers ATOS
From Benzinga
Interesting ALDX Put And Call Options For March 2022
Investors in Aldeyra Therapeutics Inc (ALDX) saw new options become available this week, for the March 2022 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
First Week of August 20th Options Trading For Aldeyra Therapeutics (ALDX)
Investors in Aldeyra Therapeutics Inc (ALDX) saw new options become available this week, for the August 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDX... 
Tags Stocks
From Market News Video
Aldeyra Therapeutics Joins the Russell 2000® and Russell 3000® Indexes
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that the company was... 
From Business Wire News Releases
Aldeyra Therapeutics Clears Key Benchmark, Hitting 90-Plus RS Rating
Aldeyra Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
Analysts Expect XBI Will Reach $216
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the... 
From Business Wire News Releases
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics, And More
Insider buying can be an encouraging signal for investors, especially when markets are near all-time highs. Some insiders have taken advantage of initial public offerings. A few chief executive... 
Tags Market News Stocks / Equities
From Blogs - TalkMarkets
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, ... 
Tags eli lilly VACC TRUP
From Benzinga
Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript
ALDX earnings call for the period ending March 31, 2021. 
Tags ALDX Market News
From Motley Fool
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BLPH SPRO AGTC
From Benzinga
Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
Thinking about buying stock in Aurora Mobile, Sundial Growers, Oil States International, Aldeyra Therapeutics, or AMC Entertainment?
InvestorsObserver issues critical PriceWatch Alerts for JG, SNDL, OIS, ALDX, and AMC. 
From PR Newswire
Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
The drugmaker is also looking for its highest sales ever in 2021 in large part because of remdesivir. 
Tags GILD Market News LGND
From Motley Fool
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA ... 
Tags CTLT ABUS JAZZ
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. ... 
Tags NMRD Top Gainers Movers
From Benzinga
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2021 Financial Results and Discuss Recent Business Highlights
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, May 6, 2021 to report financial results for the quarter ended March 31, 2021 and discuss recent... 
From Business Wire News Releases
60 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently ... 
Tags Top Gainers BIVI VTGN
From Benzinga
Aldeyra Therapeutics, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
Why Aldeyra Therapeutics Stock Is Sinking Today
The company plans to conduct a public stock offering. 
Tags Market News ALDX
From Motley Fool
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an ... 
Tags BOXL UXIN BNTC
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market ... 
Tags BZI/TFM ALDX MNMD
From Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SRDX Earnings PRVB
From Benzinga
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The ... 
Tags DB ANY News
From Benzinga
Aldeyra Seeks To Raise $125M Via Equity To Support Reproxalap US Application
Aldeyra Therapeutics Inc(NASDAQ:ALDX)intends to sell $125 millionshares of its common stock in an ... 
Tags News Offerings Market News
From Benzinga
52 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) ... 
Tags BTX TIRX CROX
From Benzinga
Stocks To Watch: Aldeyra Therapeutics Sees RS Rating Jump To 96
Aldeyra Therapeutics sees its Relative Strength Rating reach the elite 90-plus level. 
From Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.